![](/img/cover-not-exists.png)
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer
Stefan Madajewicz, David M. Waterhouse, Paul S. Ritch, M. Qaseem Khan, Donald J. Higby, Cynthia G. Leichman, Sandeep K. Malik, Patricia Hentschel, John F. Gill, Luping Zhao, Steven J. NicolVolume:
30
Language:
english
Pages:
7
DOI:
10.1007/s10637-010-9598-9
Date:
April, 2012
File:
PDF, 123 KB
english, 2012